\nBugetul alocat medicamentelor \u00een Rom\u00e2nia, \u00een prezent, este \u00een valoare de 6 miliarde lei \u015fi este calculat la nivelul consumului de medicamente din anul 2011, \u00een condi\u0163iile \u00een care, \u00een ultimii trei ani, num\u0103rul pacien\u0163ilor rom\u00e2ni si implicit nevoia acestora de a se trata a crescut cu peste 20%, se arat\u0103 \u00eentr-un comunicat al ARPIM.<\/p>\n
\nAstfel, conform celui mai recent raport al Comisiei Europene – OECD Health Data 2014, citat de Asocia\u0163ie, Rom\u00e2nia se afl\u0103 printre ultimele \u0163\u0103ri din Europa \u00een ceea ce prive\u015fte bugetul alocat medicamentelor, de 216 euro\/locuitor, fa\u0163\u0103 de media european\u0103 de 350 euro\/locuitor.<\/strong><\/p>\n \nDe asemenea, exist\u0103 o diferen\u0163\u0103 foarte mare \u015fi \u00eentre sumele alocate s\u0103n\u0103t\u0103\u0163ii \u00een Rom\u00e2nia comparativ cu alte \u0163\u0103ri europene. Astfel, Rom\u00e2nia, cu doar 753 euro\/locuitor, se afl\u0103 pe ultimele locuri, al\u0103turi de Macedonia \u015fi Turcia, \u00een timp ce pe primul loc la acest capitol se afl\u0103 Olanda, care aloc\u0103 3.829 euro\/locuitor, urmat\u0103 de Danemarca – 3.528 euro\/locuitor \u015fi de Luxembourg – 3.437 euro\/locuitor.<\/p>\n \n“Subfinan\u0163area bugetului alocat pentru medicamente este, \u00een prezent, una dintre cele mai grave probleme ale sistemului de s\u0103n\u0103tate. Rom\u00e2nia a ajuns s\u0103 fie printre primele \u0163\u0103ri din Europa \u00een ceea ce prive\u015fte mortalitatea din cauze evitabile \u015fi printre ultimele \u0163\u0103ri c\u00e2nd vine vorba de speran\u0163a de via\u0163\u0103. Alocarea procentual\u0103 din PIB pentru s\u0103n\u0103tate trebuie s\u0103 creasc\u0103 \u00eentr-un ritm constant de la 4% c\u00e2t este acum, astfel \u00eenc\u00e2t s\u0103 poat\u0103 atinge media european\u0103 de 6,5%. Doar \u00een condi\u0163iile unei finan\u0163\u0103ri corecte \u015fi raportate la nevoile reale ale pacien\u0163ilor rom\u00e2ni, sistemul rom\u00e2nesc de s\u0103n\u0103tate le va putea oferi acestora acces permanent la servicii medicale corecte \u015fi medicamente moderne”, a declarat Dan Zaharescu, directorul executiv al ARPIM.<\/p>\n \nARPIM este organiza\u0163ia care sus\u0163ine obiectivele comune ale celor mai importante 28 de companii farmaceutice interna\u0163ionale produc\u0103toare de medicamente originale, prezente \u00een Rom\u00e2nia. <\/strong>Acestea realizeaz\u0103 \u00eempreun\u0103 peste 70% din valoarea pie\u0163ei farmaceutice rom\u00e2ne\u015fti.<\/p>\n \nCompaniile farmaceutice membre ARPIM sunt: Abbott, Abbvie, Alcon, Amgen, Angelini Pharmaceuticals, Astellas Pharma, AstraZeneca, Bayer, Berlin-Chemie A. Menarini, Boehringer Ingelheim, Boiron, Bristol Myers Squibb, Chiesi, Eli Lilly, GlaxoSmithKline, Ipsen, Johnson & Johnson, Lundbeck, Merck Romania, Merck Sharp & Dohme, Novartis Pharma Services Romania, Novo Nordisk Farma, Pfizer, Sanofi Aventis, Servier Pharma, Takeda Pharmaceuticals, UCB Pharma, Vifor Pharma.<\/p>\n","protected":false},"excerpt":{"rendered":" Diferen\u0163a dintre sumele alocate pentru medicamente \u015fi nevoile de tratament ale pacien\u0163ilor este de 1,25 miliarde lei, arat\u0103 Asocia\u0163ia Rom\u00e2n\u0103 a Produc\u0103torilor Interna\u0163ionali de Medicamente (ARPIM), preciz\u00e2nd c\u0103 bugetul este calculat la nivelul consumului de medicamente din anul 2011.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[13854,39024],"class_list":["post-115502","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-arpim","tag-bugetul-sanatatii"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/115502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=115502"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/115502\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=115502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=115502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=115502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}